The gastrointestinal tract "tastes" nutrients: evidence from the intestinal taste aversion paradigm.
To develop and use a behavioral paradigm for assessments of what nutrient properties are detected by intestinal chemoreceptors, we combined features of the "electronic esophagus" preparation (Elizalde G and Sclafani A. Physiol Behav 47: 63-77, 1990) and the conditioned taste aversion protocol (Garcia J and Koelling RA. Psychon Sci 4: 123-124, 1966). In four experiments, separate groups of food-deprived rats with gastric (experiments 1-4) or duodenal (experiment 4) catheters were infused with either carbohydrates (maltodextrin) or fats (corn oil) into their stomachs or small intestines, either while they consumed nonnutritive flavored solutions (experiments 1 and 2) or in the absence of any intake (experiments 3 and 4). For some animals, one of the macronutrient infusions was paired with lithium chloride injections shown to support conventional conditioned aversions. After training, in various oral preference test trials, animals were given opportunities to taste and consume the nonnutritive solutions that had served as oropharyngeal conditioned stimuli as well as the nutrients that had been infused intragastrically, with or without poisoning, but never sampled by mouth. As previously established, preferences for the nonnutritive flavors were enhanced by association with intragastric infusions of macronutrients, with carbohydrates producing the greater preference. On first exposure to the two macronutrients for oral consumption, animals reduced their intake of the nutrient that had been previously poisoned when it was infused into the gastrointestinal tract. These results, along with additional controls, suggest that nutrient tastes detected in the intestines can be recognized centrally based on oropharyngeal gustatory stimulation.
Tracy
Andrea L
AL
Department of Psychological Sciences, Purdue University, W. Lafayette, IN 47907, USA. atracy@psych.purdue.edu
Phillips
Robert J
RJ
Chi
Michael M
MM
Powley
Terry L
TL
Davidson
T L
TL
D000818:Animals; D001362:Avoidance Learning / Q000502:physiology*; D001835:Body Weight / Q000502:physiology; D002628:Chemoreceptor Cells / Q000502:physiology; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology; D003314:Corn Oil / Q000494:pharmacology; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000494:pharmacology; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology; D004386:Duodenum / Q000502:physiology; D004943:Esophagogastric Junction / Q000502:physiology; D007422:Intestines / Q000502:physiology*; D007441:Intubation, Gastrointestinal; D018021:Lithium Chloride / Q000494:pharmacology; D008297:Male; D011134:Polysaccharides / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013649:Taste / Q000187:drug effects / Q000502:physiology*
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D011134:Polysaccharides; C008315:maltodextrin; D003314:Corn Oil; D018021:Lithium Chloride